Data by Company within Laboratory Analytical Instruments Industry
|
| |
Marketcap |
Revenues (TTM) |
Net Income (TTM) |
Employees |
| Company |
(Millions) |
(Millions) |
(Millions) |
Number |
| Agilent Technologies inc |
$ 40,248 |
$ 6,511 |
$ 1,176 |
18,100 |
| Mettler Toledo International Inc |
$ 29,805 |
$ 3,750 |
$ 786 |
18,000 |
| Illumina Inc |
$ 20,594 |
$ 4,429 |
$ -3,044 |
11,500 |
| Avantor Inc |
$ 18,567 |
$ 6,826 |
$ 360 |
- |
| Revvity Inc |
$ 15,163 |
$ 2,154 |
$ 560 |
16,700 |
| Bruker Corporation |
$ 9,616 |
$ 2,818 |
$ 322 |
6,900 |
| Bio rad Laboratories Inc |
$ 9,378 |
$ 2,562 |
$ -1,326 |
8,200 |
| Olink Holding Ab publ |
$ 3,297 |
$ 169 |
$ -32 |
267 |
| 10x Genomics Inc |
$ 2,569 |
$ 574 |
$ -266 |
1,500 |
| Singular Genomics Systems Inc |
$ 937 |
$ 3 |
$ 89 |
- |
| Cytek Biosciences Inc |
$ 672 |
$ 197 |
$ -18 |
300 |
| Pacific Biosciences Of California Inc |
$ 504 |
$ 188 |
$ -400 |
500 |
| Quanterix Corp |
$ 497 |
$ 128 |
$ -36 |
359 |
| Nautilus Biotechnology Inc |
$ 371 |
- |
$ -70 |
- |
| Eyepoint Pharmaceuticals Inc |
$ 339 |
$ 43 |
$ -100 |
- |
| Standard Biotools Inc |
$ 165 |
$ 105 |
$ -76 |
- |
| Akoya Biosciences Inc |
$ 145 |
$ 87 |
$ -70 |
- |
| Harvard Bioscience Inc |
$ 127 |
$ 99 |
$ -11 |
289 |
| Kewaunee Scientific Corporation |
$ 108 |
$ 202 |
$ 19 |
1,357 |
| Seer Inc |
$ 107 |
$ 16 |
$ -91 |
- |
| Phenomex Inc |
$ 99 |
$ 72 |
$ -125 |
- |
| Prenetics Global Limited |
$ 52 |
$ 22 |
$ -65 |
- |
| Rapid Micro Biosystems Inc |
$ 36 |
$ 23 |
$ 0 |
- |
| Accelerate Diagnostics Inc |
$ 35 |
$ 10 |
$ -38 |
- |
| Isoplexis Corporation |
$ 30 |
$ 17 |
$ -106 |
- |
| Bionano Genomics Inc |
$ 28 |
$ 35 |
$ -199 |
- |
| Astrotech Corp |
$ 13 |
$ 1 |
$ -11 |
42 |
| Lifeloc Technologies Inc |
$ 11 |
$ 9 |
$ 0 |
- |
| Scientific Industries Inc |
$ 11 |
$ 11 |
$ -9 |
- |
| Precipio inc |
$ 9 |
$ 17 |
$ -4 |
- |
| Cue Health Inc |
$ 7 |
$ 71 |
$ -373 |
51 |
| |
$ 5 |
$ 1 |
$ 0 |
- |
| Talis Biomedical Corporation |
$ 3 |
$ 2 |
$ -75 |
- |
| Htg Molecular Diagnostics Inc |
$ 1 |
$ 6 |
$ -20 |
- |
| Thermogenesis Holdings Inc |
$ 1 |
$ 9 |
$ -16 |
- |
| Pressure Biosciences Inc |
$ 1 |
$ 2 |
$ -33 |
- |
| Codex Dna Inc |
- |
$ 7 |
$ -19 |
- |
| Laboratory Analytical Instruments Industry |
$ 153,553 |
$ 31,173 |
$ -3,320 |
84,065 |
Recent News from Laboratory Analytical Instruments Industry |
|
Financing Agreement
Navigating Challenges, Generating Opportunities: EyePoint Pharmaceuticalsn Strategic Inducement Awards
EyePoint Pharmaceuticals Inc., a prominent player in the market for retinal disease therapeutics, is making the headlines with its recent strategic decision to grant non-statutory stock options to new employees. By utilizing NASDAQ Listing Rule 5635(...
|
|
|
Product Service News
In a groundbreaking announcement that promises to reshape the landscape of reproductive health, Pacific Biosciences of California Inc. (PacBio) unveiled the HiFi Solves Sub-fertility Consortium this month. This innovative collaboration aims to utilize the power of HiFi sequencing to advance diagnostics and treatment options for subfertility and recurrent ...
|
|
|
Stock Market Announcement
Precipio Announces Employee Stock Option Plan Repricing: Analysis and Impact on Shareholders
On (date), Precipio Inc. announced the repricing of their Employee Stock Option Plan, outlining the rationale behind this decision and detailing its potential impact on shareholders. With a total of 1.463543 million shares outstanding and a current price per s...
|
|
|
Partnership
In a groundbreaking venture, Revio is set to become a pivotal player in the realm of genetic research. The company's highly accurate long-read sequencing technology will spearhead initiatives at Münster University Hospital, aiming to unlock mysteries surrounding male infertility and rare diseases. This move also places Revio at the forefront of Germany's ...
|
|
|
Management Announcement
Cytek Biosciences, a leading player in the healthcare sector, recently made headlines with its announcement that its San Diego reagent manufacturing facility has been awarded EN ISO 13485:2016 Quality Management System (QMS) certification. However, this accomplishment comes at a time when the company is grappling with financial challenges, as re...
|
|
|
Merger and Acquisition
In a significant move set to reshape the landscape of the sports nutrition market, Prenetics Global Limited (NASDAQ: PRE), a leading player in laboratory analytical instruments, has announced the acquisition of Europa Sports Partners. This partnership positions Prenetics to leverage Europa's vast distribution network of over 10,000 gyms across the Un...
|
|
|
Stock Market Announcement
EyePoint Pharmaceuticals Grants Inducement Awards to New Employees Outside of Long-Term Incentive Plan
EyePoint Pharmaceuticals, a leading developer and marketer of therapeutics for serious retinal diseases, has recently announced the granting of non-statutory stock options to new employees. This move comes as part of the company's commitment to attra...
|
|
|
Business Update
'Santa Clara, Calif. -' Agilent Technologies Inc. (NYSE: A), a leading figure in life sciences, diagnostics, and applied chemical markets, has once again demonstrated its commitment to pioneering innovation with the launch of its new Agilent JandW 5Q GC/MS Columns. This latest offering marks a significant milestone in gas chromatography/mass spectrometry ...
|
|
|
Accelerate Diagnostics Inc
Accelerate Diagnostics Inc (AXDX) managed to reduce its diminishing returns despite facing a decline in revenues for the financial period ending on June 30, 2024. Revenues decreased by approximately 4.394% to $2.68 million during this period. Furthermore, the shortfall per share depreciated to $-0.50, a significant improvement compared to the $-2.97 EPS r...
|
|
|
Dividend
Bruker Corporation (Nasdaq: BRKR) has recently made an exciting announcement for its shareholders. The company's Board of Directors has approved the payment of a quarterly cash dividend of $0.05 per share on the Company's common stock. This news is set to benefit stockholders, as they will receive their dividend on September 16, 2024, if they ar...
|
|
|
Stocks on the Move
The shares of Talis Biomedical Corporation (NASDAQ: TLIS) have experienced a significant sell-off in recent trading sessions, plummeting by 49% to $4.58. This drastic decrease has raised concerns among investors and has been influenced by multiple news articles, including company board restructuring, potential bankruptcy filings, and negative market senti...
|
|
|
Revvity Inc
Navigating the Financial Landscape: Revvity Inc.?s Mixed Bag of Results
By
As I comb through the latest financial results from Revvity Inc. (NYSE: RVTY), it becomes clear that the company is exhibiting a unique dichotomy in its performance. The financial period ending June 30, 2024, has brought both challenges and successes, and while revenue has...
|
|
|
Business Update
'The Intersection of Innovation and Collaboration: Bruker?s Strategic Moves in Drug Discovery and Diagnostics'In the rapidly evolving landscape of biomedicine, few companies are as poised to make a significant impact as Bruker Corporation (NASDAQ: BRKR). Renowned for its cutting-edge scientific instruments and analytical technologies, Bruker is doubling d...
|
|
|
Partnership
In an exciting development for genetic research and clinical diagnostics, Singapore's National Precision Medicine (NPM) programme announced a strategic partnership with Pacific Biosciences (PacBio), a global leader in high-fidelity sequencing technology. This collaboration aims to leverage PacBio's state-of-the-art HiFi sequencing technology to explore an...
|
|
|
Partnership
Advancing Precision Medicine in Southeast Asia: Singapore's National Precision Medicine Programme Teams Up with PacBioIn a significant development for the field of genomics and precision medicine, Singapore's National Precision Medicine (NPM) programme has announced a strategic partnership with Pacific Biosciences of California, Inc. (PacBio) to implemen...
|
|
|
Business Update
In a significant advancement for cancer diagnostics and treatment, Agilent Technologies Inc. has announced the receipt of FDA approval for its MAGE-A4 IHC 1F9 pharmDx (SK032). This advancement heralds a crucial step towards enhancing patient care in those diagnosed with synovial sarcoma, a rare and aggressive form of cancer. By enabling clinicians to iden...
|
|
|
Clinical Study
'Abstract' Bionano Genomics, Inc. has announced its participation in the Cancer Genomics Consortium (CGC) 2024 Annual Meeting, showcasing the utility of optical genome mapping (OGM) in cancer research. This article reviews the significance of OGM, the content presented at the meeting, and its implications for the study of hematological malignancies.'' I...
|
|
|
Product Service News
''In a remarkable convergence of technology and biological analysis, Cytek Biosciences is redefining the landscape of cellular diagnostics and analysis through a series of groundbreaking innovations. With the introduction of the SpectroPanel, an advanced automated panel design tool, alongside enhanced capabilities in small particle detection and the launc...
|
|
|
Business Update
''In a significant breakthrough for Alzheimer?s disease (AD) detection and diagnosis, Quanterix Corporation (NASDAQ: QTRX) has unveiled promising data at the recent Alzheimer?s Association International Conference (AAIC) that advocates for a novel multi-marker testing framework, positioning it as a more effective strategy compared to the traditional stand...
|
|
|
Dividend
In a recent press release, Revvity (NYSE: RVTY) announced its declaration of a regular quarterly dividend of $0.07 per share of common stock. This news comes amidst positive market performance, with Revvity Inc stock witnessing significant growth in recent weeks.
Revvity's Quarterly Dividend Announcement:
WALTHAM, Mass. ?? The Boar...
|
|
|
Stocks on the Move
Agilent Technologies Expands Portfolio with $925 Million Acquisition of BiovectraIn a strategic move to enhance its service offerings to biotech companies and medical professionals, Agilent Technologies has announced its acquisition of contract drug manufacturer Biovectra for $925 million. The California-based biopharma firm aims to broaden its capabiliti...
|
|
|
Stocks on the Move
This week, Waters Corp has seen its shares underperforming in comparison to the overall market, experiencing a decline in performance. Additionally, Waters Corp customers have witnessed a slight decrease in share value throughout the year. While the company's suppliers have faced deteriorating revenues, the sales have shown sequential growth. This article...
|
|
|
Product Service News
Unleashing the Power of Long-Read Sequencing: Novogene Revolutionizes Research and Opens New Doors for Precision MedicineIn a groundbreaking move that promises to propel cancer, rare disease, and environmental research to new heights, Novogene, a global leader in genomic services and solutions, has announced the launch of its state-of-the-art laboratory i...
|
|
|
Clinical Study
In the ever-evolving landscape of cancer research, Bionano Genomics, Inc. has made promising strides with their groundbreaking optical genome mapping (OGM) technology. The company's recent publication showcases the utility of OGM in multiple myeloma (MM), solid tumor cancers, and hereditary breast and ovarian cancer (HBOC) syndrome. These studies have not...
|
|
|
Business Update
In a significant development related to ongoing patent litigation with 10x Genomics, Bruker Corporation has successfully posted a bond authorized by the Munich Higher Regional Court. This move has led to the immediate suspension of the injunction that was adversely affecting the sales of NanoString's CosMx Spatial Molecular Imager (SMI) products in German...
|
|
|
Stocks on the Move
Pacific Biosciences of California Inc (PACB) is a leading biotechnology company that specializes in innovative genomic sequencing systems. Despite recent market challenges and fluctuations, PACB has managed to maintain its position as a player in the biotech industry. This article will explore the key factors contributing to the company's success, includi...
|
|
|
Shares
EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a leading company in developing therapeutics for serious retinal diseases, has once again made headlines with its recent announcement of granting non-statutory stock options to new employees as inducement awards. This decision, made outside of the company's existing Long-Term Incentive Plan, is in accord...
|
|
|
Stock Market Announcement
Singular Genomics Regains Compliance with Nasdaq Minimum Bid Price Requirement
SAN DIEGO, July 15, 2024 - Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company specializing in next-generation sequencing and spatial multiomics technologies, announced today that it has regained compliance with Nasdaq's minimum bid price requirement under Nasdaq List...
|
|
|
Stocks on the Move
The genomics industry has experienced significant growth in recent years, offering innovative products for biological analysis. However, 10x Genomics now finds itself facing tough times as it grapples with declining revenues and heavy losses in key products. This downward trend has been exacerbated by competitor Illumina's recent acquisition of Fluent Bio...
|
|
|
Partnership
'Prenetics Partners with David Beckham to Launch New Health and Wellness Brand''LOS ANGELES, July 11, 2024' ?? Prenetics (NASDAQ: PRE), a prominent company in the health sciences sector, has announced a strategic partnership with former international footballer David Beckham. Beckham, who is also recognized for his entrepreneurial efforts and philanthropy...
|
|
|
|
|
|
